Satoru Nihei

8PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursEpidemiological modellingOral and maxillofacial surgery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 03, 2026
Timing of bone-modifying agent initiation and skeletal-related event risk in patients with bone metastases from solid tumors: a retrospective landmark and propensity score-matched analysis.

|Jun 26, 2026
VEGF inhibitor-induced proteinuria: the role of hypertension and vascular endothelial dysfunction.

|Dec 23, 2025
Timing of bone-modifying agents after bone metastasis diagnosis and time to first skeletal-related event: A systematic review and study-level correlation analysis.

Junya Sato, Tatsuki Ikeda, Satoru Nihei

|Apr 17, 2025
Potential role of endothelial dysfunction in hypertension and proteinuria in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab: a pilot prospective observational study.

Satoru Nihei, Kazuki Saito, Tatsuki Ikeda

|Aug 23, 2024
Effect of blood pressure control on the risk of proteinuria during bevacizumab treatment in patients with colorectal cancer: a single-center retrospective cohort study.

Satoru Nihei, Junichi Asaka, Mizunori Yaegashi

|Apr 10, 2023
Plasma endothelin-1 may predict bevacizumab-induced proteinuria in patients with colorectal cancer.

Satoru Nihei, Tatsuki Ikeda, Tomohiko Aoki

Pageof 2

Frequent Collaborators

2 joint publications

Junya Sato

2 joint publications

Tatsuki Ikeda

2 joint publications

Kenzo Kudo

1 joint publications

Rei Tanaka